(Bloomberg) — The U.K. government imposed tougher curbs on London in a bid to contain a spike in new cases, while France set a curfew in Paris. European nations from Germany to Italy to the Czech Republic reported record increases in new infections.
An experimental coronavirus vaccine developed by Translate Bio Inc. and French drug giant Sanofi elicited high levels of protective neutralizing antibodies in early-stage animal studies, clearing the way for a clinical trial to start later this year. Germany’s health minister warned that the nation’s tracing capacity is nearing its limit.
Singapore and Hong Kong will create a travel bubble that exempts people from both cities from quarantine, an agreement that will re-open links between Asia’s two premier financial hubs. India reported fewer than 70,000 cases for the fourth straight day, though daily infections are still higher than in the U.S.
Global Tracker: Cases pass 38.5 million; deaths top 1.09 millionCovid’s deadly U.S. comeback widens, spreads to 46 statesWho’s succeeding against the coronavirus and why: QuickTakeRussia to miss Covid-19 vaccine goal amid production hurdlesEnergy demand will get a work-from-home boost this winterThe global economy is facing new fiscal cliffs
Subscribe to a daily update on the virus from Bloomberg’s Prognosis team here. Click CVID on the terminal for global data on coronavirus cases and deaths.
Argentina Now Among Top Five Most-Infected Countries (9:12 a.m. NY)
A patchy lockdown that’s dragged on for 210 days has failed to spare Argentina from a late and aggressive outbreak of coronavirus.
Argentina passed Colombia as the most-infected country in Latin America after only Brazil and is currently number five globally in overall cases trailing the U.S., India, its northern neighbor and Russia. In total, 931,967 people have tested positive while 24,921 fatalities have been reported.
Germany Warns Tracing Capacity Near Limits (8:51 a.m. NY)
Chancellor Angela Merkel’s top health official warned that the recent surge in coronavirus infections is threatening Germany’s ability to track cases and check the spread of the disease.
“The problem is that day by day with increasing numbers our local authorities are not able any more to trace,” Health Minister Jens Spahn said Thursday during a Bloomberg webinar. “And then you lose track” and the numbers are increasing exponentially, he added.
Sanofi Plans Human Trial of mRNA Vaccine (8:14 a.m. NY)
Two doses of the candidate induced neutralizing antibodies “significantly higher” than those observed in Covid-19 patients as well as a response in infection-fighting T-cells in non-human primates, Translate Bio and Sanofi said in a statement.
The candidate is a so-called messenger RNA vaccine, which prompts the body to make a key protein from the virus, sparking an immune response. It’s based on technology similar to that used by one of the fastest-moving vaccine developers, Moderna Inc.
Sanofi is developing another coronavirus vaccine in collaboration with GlaxoSmithKline Plc. That shot is already in a clinical trial, and first results are expected in early December to support the start of a broader phase